43.1 GENETIC INSIGHTS LEAD TO DISCOVERY OF SELECTIVE ACTIVATORS OF MGLU1 AND MGLU3 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TREATMENTS FOR SCHIZOPHRENIA

BACKGROUND: A large number of clinical and preclinical studies suggest that dysfunction at synapses for the excitatory neurotransmitter glutamate may play a critical role in the pathophysiological changes that underlie each of the major symptom clusters observed in schizophrenia patients. Interestin...

Descripción completa

Detalles Bibliográficos
Autores principales: Conn, P Jeffrey, Yohn, Samantha, Stansley, Branden, Foster, Dan, Plumley, Hyekyung, Lindsley, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887675/
http://dx.doi.org/10.1093/schbul/sby014.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887675/
http://dx.doi.org/10.1093/schbul/sby014.179

Ejemplares similares